SOURCE: Bio-Matrix Scientific Group Inc.

February 23, 2010 08:00 ET

Bio-Matrix Scientific Group to Host Conference Call to Update Shareholders on New Developments in the Company

Call Slated for March 23, 2010 on an RSVP Basis

SAN DIEGO, CA--(Marketwire - February 23, 2010) - Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) announced today that it will be hosting a conference call to update shareholders on current developments at the Company and outline management's plans for the Company going forward.

David Koos, the Company's Chairman & CEO, stated, "By holding this conference call, the Company believes it can more efficiently update our shareholders on developments currently underway including those taking place with its majority owned subsidiary Entest BioMedical, Inc. (OTCBB: ENTB). Our shareholders can email or fax questions to the Company that will be addressed on the call."

The conference call will not have an open Questions & Answers session, but the Company is inviting shareholders to email or fax their questions so they may be addressed during the call. The Company currently anticipates the conference call will take place March 23, 2010 at 1:00 p.m. PST. Those wishing to participate in the call are requested to email or fax their name, email address and any questions they wish addressed during the call to (email) or 619.330.2328(fax) prior to March 10, 2010. Instructions, including call in number and access codes, will be emailed to participants once details have been finalized.

About Bio-Matrix Scientific Group:

Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) is a biotechnology company headquartered in San Diego, Ca. with a 15,000 sq. ft. facility that houses two secure cryogenic stem cell banks, three research laboratories, aseptic cellular/tissue class 10,000/100 processing lab, hematology, microbiology and flow cytometry laboratories. David Koos concurrently serves as Chairman & CEO of Bio-Matrix Scientific Group Inc. and Entest Biomedical, Inc. (OTCBB: ENTB). Entest Biomedical, Inc. is a majority owned subsidiary of Bio-Matrix Scientific Group Inc.

Forward-looking statements:

This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to the effect of government regulation, competition and other material risks.

Contact Information

  • David R. Koos,
    Chairman & CEO
    Bio-Matrix Scientific Group Inc.
    Entest BioMedical, Inc.

    619.702.1404 Direct
    619.330.2328 Fax
    Email Contact